PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
This esteemed award, marking the company's second consecutive win among global CDMO companies, is a testament to PharmaBlock's persistent commitment to green chemistry and its unwavering efforts in crafting innovative, sustainable solutions for the pharmaceutical industry.
- This esteemed award, marking the company's second consecutive win among global CDMO companies, is a testament to PharmaBlock's persistent commitment to green chemistry and its unwavering efforts in crafting innovative, sustainable solutions for the pharmaceutical industry.
- These compounds are vital in the pharmaceutical industry and serve as raw materials or key intermediates for many marketed drugs.
- PharmaBlock has been developing a comprehensive suite of solutions, featuring flow chemistry, micropacked bed hydrogenation, biocatalysis, immobilized catalysis, etc.
- "We are thrilled to receive the CMO Excellence in Green Chemistry Award for the second consecutive year.